-Joel M Reid Researcher Activity Profile

Research Author Detailed Information 

Joel M Reid Publication Rate By Year

Joel M Reid has published 1 paper(s) in 1989, 8 paper(s) in 2006, 16 paper(s) in 2007, 15 paper(s) in 2008, for a total of 40 research publications in total.

Joel M Jm Reid Author Information

LAST NAME: reid

FIRST NAME: Joel M

INITIALS: jm

AFFILIATION:

Papers

Joel M Reid's Publication Record

1. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group. Year Published: 2007
Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239-3098, USA. malempat@ohsu.edu
2. A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors. Year Published: 2006
Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.
3. Spatial variation in demography and population growth rate: the importance of natal location. Year Published: 2006
School of Biological Sciences, University of Aberdeen, UK. jane.reid@abdn.ac.uk
4. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Year Published: 2006
National Cancer Registry Ireland, Cork, Ireland.
5. A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies. Year Published: 2006
Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
6. Long-term maternal effect on offspring immune response in song sparrows Melospiza melodia. Year Published: 2006
School of Biological Sciences, Zoology Building, University of Aberdeen, Tillydrone Avenue, Aberdeen AB24 2TZ, UK. jane.reid@abdn.ac.uk
7. A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study. Year Published: 2007
University of Minnesota Cancer Center and Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA. weige007@umn.edu
8. A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin. Year Published: 2007
Division of Biostatistics, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
9. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Year Published: 2007
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
10. External validation of a six simple variable model of stroke outcome and verification in hyper-acute stroke. Year Published: 2007
Institute of Neurological Sciences, 1345 Govan Road, Glasgow G51 4TF, Scotland, UK. johnmreid@doctors.net.uk
11. Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Year Published: 2007
Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
12. Pharmacokinetics of intravitreal ranibizumab (lucentis). Year Published: 2007
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
13. A case-control study of tissue plasminogen activator for acute ischemic stroke. Year Published: 2007
Institute of Neurological Sciences, 1345 Govan Road, Glasgow, Scotland, UK G51 4TF.
14. External validation of a six simple variable model of stroke outcome and verification in hyper-acute stroke. Year Published: 2007
Institute of Neurological Sciences, 1345 Govan Road, Glasgow G51 4TF, Scotland, UK. johnmreid@doctors.net.uk
15. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Year Published: 2007
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA. sbakri@hotmail.com
16. Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorption. Year Published: 2007
Developmental Therapeutics Program, National Cancer Institute, Rm 8042, 6130 Executive Blvd., Bethesda, MD 20852, United States.
17. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Year Published: 2007
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA. sbakri@hotmail.com
18. Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group. Year Published: 2007
Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239-3098, USA. malempat@ohsu.edu
19. A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin. Year Published: 2007
Division of Biostatistics, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
20. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. Year Published: 2008
College of Physicians and Surgeons of Columbia University, New York, NY, USA. jg589@columbia.edu
21. A case-control study of tissue plasminogen activator for acute ischemic stroke. Year Published: 2007
Institute of Neurological Sciences, 1345 Govan Road, Glasgow, Scotland, UK G51 4TF.
22. On modeling the tissue response from ultrasonic B-scan images. Year Published: 2008
Biomed. Eng. & Sci. Inst., Drexel Univ., Philadelphia, PA.
23. Use of non-Rayleigh statistics for the identification of tumors in ultrasonic B-scans of the breast. Year Published: 2008
Dept. of Electr. & Comput. Eng., Drexel Univ., Philadelphia, PA.
24. PSpice modelling of ultrasound transducers: comparison of software models to experiment. Year Published: 2008
Dept. of Electr. Eng., Florence Univ.
25. Testing evolutionary models of senescence in a natural population: age and inbreeding effects on fitness components in song sparrows. Year Published: 2008
Zoological Museum, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
26. Studies on ultrasonic scattering from quasi-periodic structures. Year Published: 2008
Biomed. Eng. and Sci. Inst., Drexel Univ., Philadelphia, PA.
27. Non-Rayleigh statistics of ultrasonic backscattered signals. Year Published: 2008
Biomed. Eng. and Sci. Inst., Drexel Univ., Philadelphia, PA.
28. Spatial variation in demography and population growth rate: the importance of natal location. Year Published: 2006
School of Biological Sciences, University of Aberdeen, UK. jane.reid@abdn.ac.uk
29. Nonuniform phase distribution in ultrasound speckle analysis. I. Background and experimental demonstration. Year Published: 2008
Dept. of Electr. and Comput. Eng., Drexel Univ., Philadelphia, PA.
30. Nonuniform phase distribution in ultrasound speckle analysis. II. Parametric expression and a frequency sweeping technique to measure mean scatterer spacing. Year Published: 2008
Dept. of Electr. and Comput. Eng., Drexel Univ., Philadelphia, PA.
31. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. Year Published: 2008
College of Physicians and Surgeons of Columbia University, New York, NY, USA. jg589@columbia.edu
32. Color-flow Doppler and conventional duplex scanning of the carotid bifurcation: prospective, double-blind, correlative study. Year Published: 1989
Department of Radiology, University of British Columbia, Vancouver, Canada.
33. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears). Year Published: 2006
National Cancer Registry Ireland, Cork, Ireland. linda.sharp@ncri.ie
34. Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption. Year Published: 2007
Developmental Therapeutics Program, National Cancer Institute, Rm 8042, 6130 Executive Blvd., Bethesda, MD 20852, USA. jiale@mail.nih.gov
35. Testing evolutionary models of senescence in a natural population: age and inbreeding effects on fitness components in song sparrows. Year Published: 2008
Zoological Museum, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. lukas.keller@zm.uzh.ch
36. A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study. Year Published: 2008
Texas Children's Cancer Center/Baylor College of Medicine, Houston, Texas, USA. tmhorton@txccc.org
37. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Year Published: 2008
Institute of Neurological Sciences, 1345 Govan Road, Glasgow, UK G51 4TF. johnmreid@doctors.net.uk
38. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Year Published: 2008
Institute of Neurological Sciences, 1345 Govan Road, Glasgow, UK G51 4TF. johnmreid@doctors.net.uk
39. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears). Year Published: 2006
National Cancer Registry Ireland, Cork, Ireland. linda.sharp@ncri.ie
40. Individual phenotype, kinship, and the occurrence of inbreeding in song sparrows. Year Published: 2008
School of Biological Sciences, Zoology Building, University of Aberdeen, Tillydrone Avenue, Aberdeen AB24 2TZ, Scotland.